• Study on Long-term Safety of NVDX3 Implant for Patients with Distal Radius Fracture or Low-grade Degenerative Lumbar Spondylolisthesis

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Luxembourg
  • Study on Regorafenib for Patients with Recurrent Grade 2 and 3 Meningioma After Surgery and Radiotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on the Safety and Effects of Lutetium (177Lu) rhPSMA-10.1 Injection in Men with Advanced Prostate Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany The Netherlands
  • Study on Bupivacaine Hydrochloride and Sodium Chloride for Recovery After Minimally Invasive Colorectal Surgery

    Recruiting

    3 1 1 1
    The Netherlands
  • Study of Chemoradiation with Carboplatin and Paclitaxel for Elderly Patients with Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Effects of R3R01 on Reducing Protein in Urine for Patients with Diabetic Kidney Disease

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Long-Term Follow-Up Study for Patients with Myxoid/Round Cell Liposarcoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Synovial Sarcoma Treated with Letetresgene Autoleucel

    Recruiting

    1 1 1
    Investigated drugs:
    Italy The Netherlands Spain
  • Study on Sentinel Lymph Node Biopsy for Parotid Gland Cancer Using Gallium (68Ga) Chloride and Tilmanocept in Patients Undergoing Parotidectomy and Neck Dissection

    Recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Effect of Semaglutide in Patients with Type 1 Diabetes and Insulin Resistance

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

    Recruiting

    2 1
    Belgium Bulgaria France Germany Italy The Netherlands +3

powered by